These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28422003)

  • 1. Efficacy and safety of leflunomide as an adjuvant drug in refractory dermatomyositis with primarily cutaneous activity.
    de Souza RC; de Souza FHC; Miossi R; Shinjo SK
    Clin Exp Rheumatol; 2017; 35(6):1011-1013. PubMed ID: 28422003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leflunomide as adjuvant treatment of dermatomyositis.
    Boswell JS; Costner MI
    J Am Acad Dermatol; 2008 Mar; 58(3):403-6. PubMed ID: 18194823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effect of leflunomide in patients with Takayasu arteritis: an observational study.
    de Souza AW; da Silva MD; Machado LS; Oliveira AC; Pinheiro FA; Sato EI
    Scand J Rheumatol; 2012 May; 41(3):227-30. PubMed ID: 22400913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide use in a cytomegalovirus infection of a patient with dermatomyositis.
    Orden AO; Chuluyan JC; Colombini AC; Barbera RF
    Rheumatol Int; 2012 Jan; 32(1):273-5. PubMed ID: 21243491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis.
    Sangle VS; Sangle SR; D'Cruz DP
    Ann Rheum Dis; 2008 May; 67(5):723. PubMed ID: 18408111
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction treatment of proliferative lupus nephritis with leflunomide combined with prednisone: a prospective multi-centre observational study.
    Wang HY; Cui TG; Hou FF; Ni ZH; Chen XM; Lu FM; Xu FF; Yu XQ; Zhang FS; Zhao XZ; Zhao MH; Wang GB; Qian JQ; Cai GY; Zhu TY; Wang YH; Jiang ZP; Li YN; Mei CL; Zou WZ;
    Lupus; 2008 Jul; 17(7):638-44. PubMed ID: 18625636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin is an effective treatment for refractory cutaneous dermatomyositis.
    Galimberti F; Kooistra L; Li Y; Chatterjee S; Fernandez AP
    Clin Exp Dermatol; 2018 Dec; 43(8):906-912. PubMed ID: 29856076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds.
    Fukushima K; Eguchi N; Ohno K; Kanemoto H; Takahashi M; Igarashi H; Ohmi A; Nakashima K; Tsujimoto H
    J Vet Med Sci; 2016 Feb; 78(2):265-9. PubMed ID: 26460312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leflunomide in rheumatoid arthritis: recommendations through a process of consensus.
    Maddison P; Kiely P; Kirkham B; Lawson T; Moots R; Proudfoot D; Reece R; Scott D; Sword R; Taggart A; Thwaites C; Williams E
    Rheumatology (Oxford); 2005 Mar; 44(3):280-6. PubMed ID: 15657072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs.
    Sato M; Veir JK; Legare M; Lappin MR
    J Vet Intern Med; 2017 Sep; 31(5):1502-1507. PubMed ID: 28833582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of leflunomide combined with hormone therapy for refractory IgA nephropathy].
    Rong L; Liu ZR
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jun; 27(6):893-4. PubMed ID: 17584664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Leflunomide--a new drug for pharmacological immunomodulation].
    Wozel G; Pfeiffer C
    Hautarzt; 2002 May; 53(5):309-15. PubMed ID: 12063741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab therapy in patients with refractory dermatomyositis or polymyositis: differential effects in a real-life population.
    Unger L; Kampf S; Lüthke K; Aringer M
    Rheumatology (Oxford); 2014 Sep; 53(9):1630-8. PubMed ID: 24706995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leflunomide, a new disease-modifying drug for treating active rheumatoid arthritis in methotrexate-controlled phase II clinical trial.
    Bao C; Chen S; Gu Y; Lao Z; Ni L; Yu Q; Xu J; Li X; Liu J; Sun L; He P; Ma J; Xu S; Ding C
    Chin Med J (Engl); 2003 Aug; 116(8):1228-34. PubMed ID: 12935395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically amyopathic dermatomyositis: analysis of a monocentric cohort.
    Neri R; Barsotti S; Iacopetti V; Tripoli A; dʼAscanio A; Tavoni AG; Mosca M; Bombardieri S
    J Clin Neuromuscul Dis; 2014 Jun; 15(4):157-60. PubMed ID: 24872214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of leflunomide in treatment of steroid-dependent and steroid-resistant adult onset minimal change disease.
    Zhou J; Zhang Y; Liu G; Li J; Xu R; Huang J
    Clin Nephrol; 2013 Aug; 80(2):121-9. PubMed ID: 23458173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leflunomide as a novel treatment option in severe atopic dermatitis.
    Schmitt J; Wozel G; Pfeiffer C
    Br J Dermatol; 2004 Jun; 150(6):1182-5. PubMed ID: 15214907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of leflunomide combined with prednisone in the treatment of refractory nephrotic syndrome.
    Liu Y; Qu X; Chen W; Zhang Y; Liu L
    Ren Fail; 2016 Nov; 38(10):1616-1621. PubMed ID: 27819170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maintenance of remission with leflunomide in Wegener's granulomatosis.
    Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
    Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
    Ramanan AV; Campbell-Webster N; Ota S; Parker S; Tran D; Tyrrell PN; Cameron B; Spiegel L; Schneider R; Laxer RM; Silverman ED; Feldman BM
    Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.